Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort

BACKGROUND:To clarify early correlates and natural history of HIV long-term nonprogressors (LTNPs) since HIV diagnosis. METHODS:Patients enrolled in the French ANRS SEROCO/HEMOCO cohort with CD4 count >500 cells/mm at HIV diagnosis. LTNP status was defined as being asymptomatic, antiretroviral fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of acquired immune deficiency syndromes (1999) 2009-01, Vol.50 (1), p.19-26
Hauptverfasser: Madec, Yoann, Boufassa, Faroudy, Avettand-Fenoel, Veronique, Hendou, Samia, Melard, Adeline, Boucherit, Soraya, Surzyn, Janina, Meyer, Laurence, Rouzioux, Christine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 26
container_issue 1
container_start_page 19
container_title Journal of acquired immune deficiency syndromes (1999)
container_volume 50
creator Madec, Yoann
Boufassa, Faroudy
Avettand-Fenoel, Veronique
Hendou, Samia
Melard, Adeline
Boucherit, Soraya
Surzyn, Janina
Meyer, Laurence
Rouzioux, Christine
description BACKGROUND:To clarify early correlates and natural history of HIV long-term nonprogressors (LTNPs) since HIV diagnosis. METHODS:Patients enrolled in the French ANRS SEROCO/HEMOCO cohort with CD4 count >500 cells/mm at HIV diagnosis. LTNP status was defined as being asymptomatic, antiretroviral free, and with CD4 cell count >500 cells/mm for >8 years after HIV diagnosis. In LTNPs, we modeled the biological markersʼ progression through a joint model. Factors associated with loss of LTNP status were identified through a Cox model. RESULTS:Sixty (9%) of 664 patients were identified as LTNPs during follow-up. At enrollment, HIV RNA was ≤2.6 log copies/mL in 24% of LTNPs and HIV DNA was ≤1.85 log copies/10 peripheral blood mononuclear cells (PBMCs) in 31% vs. 3% and 8% in others. In LTNPs, HIV RNA and HIV DNA levels increased by 0.04 log copies/mL per year and 0.07 log copies/10 PBMCs per year during the first 8 years after diagnosis. LTNP status was lost in 36 subjects; baseline HIV DNA >1.85 log copies/10 PBMCs and high HIV DNA increase were associated with an increased risk of losing LTNP status [adjusted hazard ratio2.8 (1.2-6.8) and 2.2 (1.0-4.8), respectively]. CONCLUSIONS:LTNP status is established in the first years of HIV infection, low HIV DNA level at enrollment and slow increase of HIV DNA being associated with maintained LTNP status.
doi_str_mv 10.1097/QAI.0b013e31818ce709
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02868435v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67044465</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5229-db1edd5c74a44f055301d97b28f57befe5ffbe7eae55b8530a7636c2ec74b6673</originalsourceid><addsrcrecordid>eNqFkV1v0zAUhiMEYqPwDxCykEDiIps_k_iyKt1aqaxiHdxajnPSZrj2Zier9u_nqtWQdgFX5-j4ec-H3yz7SPAZwbI8_zmen-EaEwaMVKQyUGL5KjslkvO8rCr-OuWCipwTJk6ydzHeYkwKzuXb7IRIKgVj5DR7mOpgH9HEuz54i3yLZvPfOUFz14LpO-9Q59DCu3V-A2GLrry7C34dIEYfIrrw1vodNGjVOQPoe6fXzscu7kX9BtD46nqFVtPr5WR5Ppv-SCFN2vjQv8_etNpG-HCMo-zXxfRmMssXy8v5ZLzIjaBU5k1NoGmEKbnmvMVCMEwaWda0akVZQwuibWsoQYMQdZVedVmwwlBIirooSjbKvh36brRVd6Hb6vCovO7UbLxQ-xqmVVFxJh5IYr8e2HTh_QCxV9suGrBWO_BDVEWJOeeF-C9IsSy4rGgCP78Ab_0QXDpYUcYKJgXdj-UHyAQfY4D2eU-C1d5plZxWL51Osk_H3kO9heav6GhtAr4cAR2Ntm3QznTxmaMEY4bTd42y6sDtvO0hxD922EFQG9C23_x7hyd8qcEV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>233639521</pqid></control><display><type>article</type><title>Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Free E- Journals</source><source>Journals@Ovid Complete</source><creator>Madec, Yoann ; Boufassa, Faroudy ; Avettand-Fenoel, Veronique ; Hendou, Samia ; Melard, Adeline ; Boucherit, Soraya ; Surzyn, Janina ; Meyer, Laurence ; Rouzioux, Christine</creator><creatorcontrib>Madec, Yoann ; Boufassa, Faroudy ; Avettand-Fenoel, Veronique ; Hendou, Samia ; Melard, Adeline ; Boucherit, Soraya ; Surzyn, Janina ; Meyer, Laurence ; Rouzioux, Christine ; ANRS SEROCO/HEMOCO Study Group</creatorcontrib><description>BACKGROUND:To clarify early correlates and natural history of HIV long-term nonprogressors (LTNPs) since HIV diagnosis. METHODS:Patients enrolled in the French ANRS SEROCO/HEMOCO cohort with CD4 count &gt;500 cells/mm at HIV diagnosis. LTNP status was defined as being asymptomatic, antiretroviral free, and with CD4 cell count &gt;500 cells/mm for &gt;8 years after HIV diagnosis. In LTNPs, we modeled the biological markersʼ progression through a joint model. Factors associated with loss of LTNP status were identified through a Cox model. RESULTS:Sixty (9%) of 664 patients were identified as LTNPs during follow-up. At enrollment, HIV RNA was ≤2.6 log copies/mL in 24% of LTNPs and HIV DNA was ≤1.85 log copies/10 peripheral blood mononuclear cells (PBMCs) in 31% vs. 3% and 8% in others. In LTNPs, HIV RNA and HIV DNA levels increased by 0.04 log copies/mL per year and 0.07 log copies/10 PBMCs per year during the first 8 years after diagnosis. LTNP status was lost in 36 subjects; baseline HIV DNA &gt;1.85 log copies/10 PBMCs and high HIV DNA increase were associated with an increased risk of losing LTNP status [adjusted hazard ratio2.8 (1.2-6.8) and 2.2 (1.0-4.8), respectively]. CONCLUSIONS:LTNP status is established in the first years of HIV infection, low HIV DNA level at enrollment and slow increase of HIV DNA being associated with maintained LTNP status.</description><identifier>ISSN: 1525-4135</identifier><identifier>EISSN: 1944-7884</identifier><identifier>DOI: 10.1097/QAI.0b013e31818ce709</identifier><identifier>PMID: 19295331</identifier><identifier>CODEN: JDSRET</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Adult ; AIDS/HIV ; Anti-HIV Agents ; Anti-HIV Agents - therapeutic use ; Antiretroviral drugs ; Antiviral agents ; Biological and medical sciences ; biomarkers ; CD4 antigen ; CD4 Lymphocyte Count ; Cohort Studies ; Deoxyribonucleic acid ; Disease Progression ; DNA ; DNA, Viral ; DNA, Viral - blood ; Epidemiology ; Female ; France ; France - epidemiology ; Fundamental and applied biological sciences. Psychology ; HIV ; HIV Infections ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; HIV-1 - genetics ; Human immunodeficiency virus ; Human immunodeficiency virus 1 ; Human viral diseases ; Humans ; Infection ; Infectious diseases ; Life Sciences ; Male ; Medical diagnosis ; Medical sciences ; Microbiology ; Miscellaneous ; Patients ; Peripheral blood mononuclear cells ; RNA ; RNA, Viral ; RNA, Viral - blood ; Santé publique et épidémiologie ; Time Factors ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Virology ; Young Adult</subject><ispartof>Journal of acquired immune deficiency syndromes (1999), 2009-01, Vol.50 (1), p.19-26</ispartof><rights>2009 Lippincott Williams &amp; Wilkins, Inc.</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Lippincott Williams &amp; Wilkins Jan 1, 2009</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5229-db1edd5c74a44f055301d97b28f57befe5ffbe7eae55b8530a7636c2ec74b6673</citedby><cites>FETCH-LOGICAL-c5229-db1edd5c74a44f055301d97b28f57befe5ffbe7eae55b8530a7636c2ec74b6673</cites><orcidid>0000-0002-6201-1261 ; 0000-0002-3650-6105 ; 0000-0001-5707-2062 ; 0000-0002-7022-2990 ; 0000-0002-8819-7594</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,4010,27902,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21003076$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19295331$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-02868435$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Madec, Yoann</creatorcontrib><creatorcontrib>Boufassa, Faroudy</creatorcontrib><creatorcontrib>Avettand-Fenoel, Veronique</creatorcontrib><creatorcontrib>Hendou, Samia</creatorcontrib><creatorcontrib>Melard, Adeline</creatorcontrib><creatorcontrib>Boucherit, Soraya</creatorcontrib><creatorcontrib>Surzyn, Janina</creatorcontrib><creatorcontrib>Meyer, Laurence</creatorcontrib><creatorcontrib>Rouzioux, Christine</creatorcontrib><creatorcontrib>ANRS SEROCO/HEMOCO Study Group</creatorcontrib><title>Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort</title><title>Journal of acquired immune deficiency syndromes (1999)</title><addtitle>J Acquir Immune Defic Syndr</addtitle><description>BACKGROUND:To clarify early correlates and natural history of HIV long-term nonprogressors (LTNPs) since HIV diagnosis. METHODS:Patients enrolled in the French ANRS SEROCO/HEMOCO cohort with CD4 count &gt;500 cells/mm at HIV diagnosis. LTNP status was defined as being asymptomatic, antiretroviral free, and with CD4 cell count &gt;500 cells/mm for &gt;8 years after HIV diagnosis. In LTNPs, we modeled the biological markersʼ progression through a joint model. Factors associated with loss of LTNP status were identified through a Cox model. RESULTS:Sixty (9%) of 664 patients were identified as LTNPs during follow-up. At enrollment, HIV RNA was ≤2.6 log copies/mL in 24% of LTNPs and HIV DNA was ≤1.85 log copies/10 peripheral blood mononuclear cells (PBMCs) in 31% vs. 3% and 8% in others. In LTNPs, HIV RNA and HIV DNA levels increased by 0.04 log copies/mL per year and 0.07 log copies/10 PBMCs per year during the first 8 years after diagnosis. LTNP status was lost in 36 subjects; baseline HIV DNA &gt;1.85 log copies/10 PBMCs and high HIV DNA increase were associated with an increased risk of losing LTNP status [adjusted hazard ratio2.8 (1.2-6.8) and 2.2 (1.0-4.8), respectively]. CONCLUSIONS:LTNP status is established in the first years of HIV infection, low HIV DNA level at enrollment and slow increase of HIV DNA being associated with maintained LTNP status.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Anti-HIV Agents</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral drugs</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>biomarkers</subject><subject>CD4 antigen</subject><subject>CD4 Lymphocyte Count</subject><subject>Cohort Studies</subject><subject>Deoxyribonucleic acid</subject><subject>Disease Progression</subject><subject>DNA</subject><subject>DNA, Viral</subject><subject>DNA, Viral - blood</subject><subject>Epidemiology</subject><subject>Female</subject><subject>France</subject><subject>France - epidemiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV</subject><subject>HIV Infections</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>HIV-1 - genetics</subject><subject>Human immunodeficiency virus</subject><subject>Human immunodeficiency virus 1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infection</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Patients</subject><subject>Peripheral blood mononuclear cells</subject><subject>RNA</subject><subject>RNA, Viral</subject><subject>RNA, Viral - blood</subject><subject>Santé publique et épidémiologie</subject><subject>Time Factors</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Virology</subject><subject>Young Adult</subject><issn>1525-4135</issn><issn>1944-7884</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV1v0zAUhiMEYqPwDxCykEDiIps_k_iyKt1aqaxiHdxajnPSZrj2Zier9u_nqtWQdgFX5-j4ec-H3yz7SPAZwbI8_zmen-EaEwaMVKQyUGL5KjslkvO8rCr-OuWCipwTJk6ydzHeYkwKzuXb7IRIKgVj5DR7mOpgH9HEuz54i3yLZvPfOUFz14LpO-9Q59DCu3V-A2GLrry7C34dIEYfIrrw1vodNGjVOQPoe6fXzscu7kX9BtD46nqFVtPr5WR5Ppv-SCFN2vjQv8_etNpG-HCMo-zXxfRmMssXy8v5ZLzIjaBU5k1NoGmEKbnmvMVCMEwaWda0akVZQwuibWsoQYMQdZVedVmwwlBIirooSjbKvh36brRVd6Hb6vCovO7UbLxQ-xqmVVFxJh5IYr8e2HTh_QCxV9suGrBWO_BDVEWJOeeF-C9IsSy4rGgCP78Ab_0QXDpYUcYKJgXdj-UHyAQfY4D2eU-C1d5plZxWL51Osk_H3kO9heav6GhtAr4cAR2Ntm3QznTxmaMEY4bTd42y6sDtvO0hxD922EFQG9C23_x7hyd8qcEV</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Madec, Yoann</creator><creator>Boufassa, Faroudy</creator><creator>Avettand-Fenoel, Veronique</creator><creator>Hendou, Samia</creator><creator>Melard, Adeline</creator><creator>Boucherit, Soraya</creator><creator>Surzyn, Janina</creator><creator>Meyer, Laurence</creator><creator>Rouzioux, Christine</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><general>Lippincott Williams &amp; Wilkins</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><general>Lippincott, Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7T5</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-6201-1261</orcidid><orcidid>https://orcid.org/0000-0002-3650-6105</orcidid><orcidid>https://orcid.org/0000-0001-5707-2062</orcidid><orcidid>https://orcid.org/0000-0002-7022-2990</orcidid><orcidid>https://orcid.org/0000-0002-8819-7594</orcidid></search><sort><creationdate>20090101</creationdate><title>Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort</title><author>Madec, Yoann ; Boufassa, Faroudy ; Avettand-Fenoel, Veronique ; Hendou, Samia ; Melard, Adeline ; Boucherit, Soraya ; Surzyn, Janina ; Meyer, Laurence ; Rouzioux, Christine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5229-db1edd5c74a44f055301d97b28f57befe5ffbe7eae55b8530a7636c2ec74b6673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Anti-HIV Agents</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral drugs</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>biomarkers</topic><topic>CD4 antigen</topic><topic>CD4 Lymphocyte Count</topic><topic>Cohort Studies</topic><topic>Deoxyribonucleic acid</topic><topic>Disease Progression</topic><topic>DNA</topic><topic>DNA, Viral</topic><topic>DNA, Viral - blood</topic><topic>Epidemiology</topic><topic>Female</topic><topic>France</topic><topic>France - epidemiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV</topic><topic>HIV Infections</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>HIV-1 - genetics</topic><topic>Human immunodeficiency virus</topic><topic>Human immunodeficiency virus 1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infection</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Patients</topic><topic>Peripheral blood mononuclear cells</topic><topic>RNA</topic><topic>RNA, Viral</topic><topic>RNA, Viral - blood</topic><topic>Santé publique et épidémiologie</topic><topic>Time Factors</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Virology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madec, Yoann</creatorcontrib><creatorcontrib>Boufassa, Faroudy</creatorcontrib><creatorcontrib>Avettand-Fenoel, Veronique</creatorcontrib><creatorcontrib>Hendou, Samia</creatorcontrib><creatorcontrib>Melard, Adeline</creatorcontrib><creatorcontrib>Boucherit, Soraya</creatorcontrib><creatorcontrib>Surzyn, Janina</creatorcontrib><creatorcontrib>Meyer, Laurence</creatorcontrib><creatorcontrib>Rouzioux, Christine</creatorcontrib><creatorcontrib>ANRS SEROCO/HEMOCO Study Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madec, Yoann</au><au>Boufassa, Faroudy</au><au>Avettand-Fenoel, Veronique</au><au>Hendou, Samia</au><au>Melard, Adeline</au><au>Boucherit, Soraya</au><au>Surzyn, Janina</au><au>Meyer, Laurence</au><au>Rouzioux, Christine</au><aucorp>ANRS SEROCO/HEMOCO Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort</atitle><jtitle>Journal of acquired immune deficiency syndromes (1999)</jtitle><addtitle>J Acquir Immune Defic Syndr</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>50</volume><issue>1</issue><spage>19</spage><epage>26</epage><pages>19-26</pages><issn>1525-4135</issn><eissn>1944-7884</eissn><coden>JDSRET</coden><abstract>BACKGROUND:To clarify early correlates and natural history of HIV long-term nonprogressors (LTNPs) since HIV diagnosis. METHODS:Patients enrolled in the French ANRS SEROCO/HEMOCO cohort with CD4 count &gt;500 cells/mm at HIV diagnosis. LTNP status was defined as being asymptomatic, antiretroviral free, and with CD4 cell count &gt;500 cells/mm for &gt;8 years after HIV diagnosis. In LTNPs, we modeled the biological markersʼ progression through a joint model. Factors associated with loss of LTNP status were identified through a Cox model. RESULTS:Sixty (9%) of 664 patients were identified as LTNPs during follow-up. At enrollment, HIV RNA was ≤2.6 log copies/mL in 24% of LTNPs and HIV DNA was ≤1.85 log copies/10 peripheral blood mononuclear cells (PBMCs) in 31% vs. 3% and 8% in others. In LTNPs, HIV RNA and HIV DNA levels increased by 0.04 log copies/mL per year and 0.07 log copies/10 PBMCs per year during the first 8 years after diagnosis. LTNP status was lost in 36 subjects; baseline HIV DNA &gt;1.85 log copies/10 PBMCs and high HIV DNA increase were associated with an increased risk of losing LTNP status [adjusted hazard ratio2.8 (1.2-6.8) and 2.2 (1.0-4.8), respectively]. CONCLUSIONS:LTNP status is established in the first years of HIV infection, low HIV DNA level at enrollment and slow increase of HIV DNA being associated with maintained LTNP status.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>19295331</pmid><doi>10.1097/QAI.0b013e31818ce709</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6201-1261</orcidid><orcidid>https://orcid.org/0000-0002-3650-6105</orcidid><orcidid>https://orcid.org/0000-0001-5707-2062</orcidid><orcidid>https://orcid.org/0000-0002-7022-2990</orcidid><orcidid>https://orcid.org/0000-0002-8819-7594</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1525-4135
ispartof Journal of acquired immune deficiency syndromes (1999), 2009-01, Vol.50 (1), p.19-26
issn 1525-4135
1944-7884
language eng
recordid cdi_hal_primary_oai_HAL_hal_02868435v1
source MEDLINE; Journals@Ovid LWW Legacy Archive; Free E- Journals; Journals@Ovid Complete
subjects Adult
AIDS/HIV
Anti-HIV Agents
Anti-HIV Agents - therapeutic use
Antiretroviral drugs
Antiviral agents
Biological and medical sciences
biomarkers
CD4 antigen
CD4 Lymphocyte Count
Cohort Studies
Deoxyribonucleic acid
Disease Progression
DNA
DNA, Viral
DNA, Viral - blood
Epidemiology
Female
France
France - epidemiology
Fundamental and applied biological sciences. Psychology
HIV
HIV Infections
HIV Infections - drug therapy
HIV Infections - epidemiology
HIV-1 - genetics
Human immunodeficiency virus
Human immunodeficiency virus 1
Human viral diseases
Humans
Infection
Infectious diseases
Life Sciences
Male
Medical diagnosis
Medical sciences
Microbiology
Miscellaneous
Patients
Peripheral blood mononuclear cells
RNA
RNA, Viral
RNA, Viral - blood
Santé publique et épidémiologie
Time Factors
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Virology
Young Adult
title Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO/HEMOCO Cohort
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T14%3A47%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20Control%20of%20HIV-1%20Infection%20in%20Long-Term%20Nonprogressors%20Followed%20Since%20Diagnosis%20in%20the%20ANRS%20SEROCO/HEMOCO%20Cohort&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.au=Madec,%20Yoann&rft.aucorp=ANRS%20SEROCO/HEMOCO%20Study%20Group&rft.date=2009-01-01&rft.volume=50&rft.issue=1&rft.spage=19&rft.epage=26&rft.pages=19-26&rft.issn=1525-4135&rft.eissn=1944-7884&rft.coden=JDSRET&rft_id=info:doi/10.1097/QAI.0b013e31818ce709&rft_dat=%3Cproquest_hal_p%3E67044465%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=233639521&rft_id=info:pmid/19295331&rfr_iscdi=true